BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29621695)

  • 1. Incidence of isolated local breast cancer recurrence and contralateral breast cancer: A systematic review.
    Spronk I; Schellevis FG; Burgers JS; de Bock GH; Korevaar JC
    Breast; 2018 Jun; 39():70-79. PubMed ID: 29621695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second invasive breast cancers in patients treated with breast-conserving therapy.
    Wang J; Tang H; Yin K; Li X; Xie X; Hughes KS
    Eur J Surg Oncol; 2021 Oct; 47(10):2492-2498. PubMed ID: 34134902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional Recurrence Patterns in Patients With Different Molecular Subtypes of Breast Cancer.
    Cheun JH; Kim HK; Moon HG; Han W; Lee HB
    JAMA Surg; 2023 Aug; 158(8):841-852. PubMed ID: 37342035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less.
    Fisher B; Bryant J; Dignam JJ; Wickerham DL; Mamounas EP; Fisher ER; Margolese RG; Nesbitt L; Paik S; Pisansky TM; Wolmark N;
    J Clin Oncol; 2002 Oct; 20(20):4141-9. PubMed ID: 12377957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contralateral breast cancer: annual incidence and risk parameters.
    Broët P; de la Rochefordière A; Scholl SM; Fourquet A; Mosseri V; Durand JC; Pouillart P; Asselain B
    J Clin Oncol; 1995 Jul; 13(7):1578-83. PubMed ID: 7602346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries.
    Gujral DM; Sumo G; Owen JR; Ashton A; Bliss JM; Haviland J; Yarnold JR
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):19-25. PubMed ID: 20471183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of ipsilateral breast tumor recurrence after breast-conserving therapy.
    Jobsen J; van der Palen J; Riemersma S; Heijmans H; Ong F; Struikmans H
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1006-1014. PubMed ID: 25035203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.
    Prater J; Valeri F; Korol D; Rohrmann S; Dehler S
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):365-71. PubMed ID: 26298838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications.
    Krauss DJ; Kestin LL; Mitchell C; Martinez AA; Vicini FA
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):731-40. PubMed ID: 15465189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
    Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of radiotherapy on the incidence and time of occurrence of local recurrence in early-stage breast cancer after breast conserving therapy.
    Fodor J; Major T; Polgár C; Tóth J; Németh G
    Neoplasma; 2000; 47(3):181-6. PubMed ID: 11043843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy.
    Panet-Raymond V; Truong PT; McDonald RE; Alexander C; Ross L; Ryhorchuk A; Watson PH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):409-17. PubMed ID: 21288654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrence risk after previous salvage mastectomy.
    Tanabe M; Iwase T; Okumura Y; Yoshida A; Masuda N; Nakatsukasa K; Shien T; Tanaka S; Komoike Y; Taguchi T; Arima N; Nishimura R; Inaji H; Ishitobi M;
    Eur J Surg Oncol; 2016 Jul; 42(7):980-5. PubMed ID: 27055945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.
    Nottage MK; Kopciuk KA; Tzontcheva A; Andrulis IL; Bull SB; Blackstein ME
    Breast Cancer Res; 2006; 8(4):R44. PubMed ID: 16859523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Value of Ipsilateral Breast Tumor Recurrence as a Quality Indicator: Hospital Variation in the Netherlands.
    van der Heiden-van der Loo M; Siesling S; Wouters MW; van Dalen T; Rutgers EJ; Peeters PH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S522-8. PubMed ID: 25986872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for contralateral breast cancer in Chennai (Madras), India.
    Gajalakshmi CK; Shanta V; Hakama M
    Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.